社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
音浪太强
IP属地：广东
+关注
帖子 · 328
帖子 · 328
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
音浪太强
音浪太强
·
05-11
$宝济药业-B(02659)$
公司董事会主席兼控股股东集团成员刘彦君博士此前宣布，拟于三个月内通过公开市场增持公司股份，最高不超过3889.39万股H股，此举持续向市场释放了对公司长期价值的认可信号。
看
412
回复
评论
点赞
1
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
05-11
$派格生物医药-B(02565)$
派格股价稳住了，本周开始要走强
看
104
回复
评论
点赞
1
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
05-11
$苹果(AAPL)$
苹果或“小幅重新设计”macOS 27 的液态玻璃界面 曝字节跳动上调今年资本开支至逾 2000 亿元，加码 AI 基建 微信灰度测试“组合支付”：转账可同时用零钱和银行卡 曝阿里巴巴将整合千问与淘宝，推出 AI 对话购物功能 “马斯克版 Codex”曝光
看
263
回复
评论
点赞
1
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
04-22
$派格生物医药-B(02565)$
今天都是散户在跑，等待散户筹码出完就可以拉升
看
299
回复
评论
点赞
1
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
04-22
$佰泽医疗(02609)$
从业绩表现看，佰泽医疗2025年实现收入11.2亿元，经调整净利润达1,790万元，同比增长43.2%。经调整EBITDA利润率由11.4%提升至12.9%，盈利能力持续增强。
看
407
回复
评论
点赞
1
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
04-14
$华检医疗(01931)$
下午港股都在大力反弹！华检也要跟上节奏
看
727
回复
评论
点赞
1
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
04-14
$派格生物医药-B(02565)$
买单开始积极的流入，股价要冲上来
看
490
回复
评论
点赞
1
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
04-14
$腾讯音乐(TME)$
IT之家 3 月 30 日消息，杜比实验室 (Dolby Laboratories) 与 QQ 音乐本月 27 日宣布，QQ 音乐将成为首个支持杜比旗舰音频编解码技术 AC-4 的主流音乐流媒体平台，为该平台现有的杜比全景声技术实现全新升级。
看
1,744
回复
评论
点赞
4
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
03-26
$中慧生物-B(02627)$
今天的成交量不多，都是小单在跑
看
920
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
音浪太强
音浪太强
·
03-26
$同源康医药-B(02410)$
智通财经APP讯，同源康医药-B(02410)发布公告，本公司将于2026年美国癌症研究协会(AACR)年会壁报环节展示TY-0609(CDK4抑制剂)、TY-2699a(CDK7抑制剂 )、 TY-2719(EGFR/FAK(PROTAC)抑制剂)、PI3Kα(PI3Kα抑制剂)、TY-1054 (YAP-TEAD抑制剂)五个在研创新药项目的研究进展和成果，此次展示的五个项目均为本公司自主研发的抗肿瘤小分子创新候选药物。本届AACR年会将于2026 年4月17日至22日在美国圣地亚哥举行，本公司参会壁报将分别于4月19日至4月 21日展示。
看
1,090
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4108169277080930","uuid":"4108169277080930","gmtCreate":1645066207958,"gmtModify":1683718701327,"name":"音浪太强","pinyin":"yltqyinlangtaiqiang","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":4,"tweetSize":328,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.03.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":563150967267408,"gmtCreate":1778471743591,"gmtModify":1778472640700,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 公司董事会主席兼控股股东集团成员刘彦君博士此前宣布，拟于三个月内通过公开市场增持公司股份，最高不超过3889.39万股H股，此举持续向市场释放了对公司长期价值的认可信号。","listText":"<a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 公司董事会主席兼控股股东集团成员刘彦君博士此前宣布，拟于三个月内通过公开市场增持公司股份，最高不超过3889.39万股H股，此举持续向市场释放了对公司长期价值的认可信号。","text":"$宝济药业-B(02659)$ 公司董事会主席兼控股股东集团成员刘彦君博士此前宣布，拟于三个月内通过公开市场增持公司股份，最高不超过3889.39万股H股，此举持续向市场释放了对公司长期价值的认可信号。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/563150967267408","isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":562967221920360,"gmtCreate":1778471722806,"gmtModify":1778471724865,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 派格股价稳住了，本周开始要走强","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 派格股价稳住了，本周开始要走强","text":"$派格生物医药-B(02565)$ 派格股价稳住了，本周开始要走强","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/562967221920360","isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":562967105004088,"gmtCreate":1778471693473,"gmtModify":1778472635481,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$ </a> 苹果或“小幅重新设计”macOS 27 的液态玻璃界面 曝字节跳动上调今年资本开支至逾 2000 亿元，加码 AI 基建 微信灰度测试“组合支付”：转账可同时用零钱和银行卡 曝阿里巴巴将整合千问与淘宝，推出 AI 对话购物功能 “马斯克版 Codex”曝光","listText":"<a href=\"https://laohu8.com/S/AAPL\">$苹果(AAPL)$ </a> 苹果或“小幅重新设计”macOS 27 的液态玻璃界面 曝字节跳动上调今年资本开支至逾 2000 亿元，加码 AI 基建 微信灰度测试“组合支付”：转账可同时用零钱和银行卡 曝阿里巴巴将整合千问与淘宝，推出 AI 对话购物功能 “马斯克版 Codex”曝光","text":"$苹果(AAPL)$ 苹果或“小幅重新设计”macOS 27 的液态玻璃界面 曝字节跳动上调今年资本开支至逾 2000 亿元，加码 AI 基建 微信灰度测试“组合支付”：转账可同时用零钱和银行卡 曝阿里巴巴将整合千问与淘宝，推出 AI 对话购物功能 “马斯克版 Codex”曝光","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/562967105004088","isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":556289300433072,"gmtCreate":1776841397309,"gmtModify":1776841399274,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 今天都是散户在跑，等待散户筹码出完就可以拉升","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 今天都是散户在跑，等待散户筹码出完就可以拉升","text":"$派格生物医药-B(02565)$ 今天都是散户在跑，等待散户筹码出完就可以拉升","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/556289300433072","isVote":1,"tweetType":1,"viewCount":299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":556289395737224,"gmtCreate":1776841345430,"gmtModify":1776841347804,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02609\">$佰泽医疗(02609)$ </a> 从业绩表现看，佰泽医疗2025年实现收入11.2亿元，经调整净利润达1,790万元，同比增长43.2%。经调整EBITDA利润率由11.4%提升至12.9%，盈利能力持续增强。","listText":"<a href=\"https://laohu8.com/S/02609\">$佰泽医疗(02609)$ </a> 从业绩表现看，佰泽医疗2025年实现收入11.2亿元，经调整净利润达1,790万元，同比增长43.2%。经调整EBITDA利润率由11.4%提升至12.9%，盈利能力持续增强。","text":"$佰泽医疗(02609)$ 从业绩表现看，佰泽医疗2025年实现收入11.2亿元，经调整净利润达1,790万元，同比增长43.2%。经调整EBITDA利润率由11.4%提升至12.9%，盈利能力持续增强。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/556289395737224","isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":553431460623408,"gmtCreate":1776149672444,"gmtModify":1776150248634,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/01931\">$华检医疗(01931)$ </a> 下午港股都在大力反弹！华检也要跟上节奏","listText":"<a href=\"https://laohu8.com/S/01931\">$华检医疗(01931)$ </a> 下午港股都在大力反弹！华检也要跟上节奏","text":"$华检医疗(01931)$ 下午港股都在大力反弹！华检也要跟上节奏","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/553431460623408","isVote":1,"tweetType":1,"viewCount":727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":553431328351816,"gmtCreate":1776149647496,"gmtModify":1776149649608,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 买单开始积极的流入，股价要冲上来","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 买单开始积极的流入，股价要冲上来","text":"$派格生物医药-B(02565)$ 买单开始积极的流入，股价要冲上来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/553431328351816","isVote":1,"tweetType":1,"viewCount":490,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":553431179998824,"gmtCreate":1776149623644,"gmtModify":1776149626138,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/TME\">$腾讯音乐(TME)$ </a> IT之家 3 月 30 日消息，杜比实验室 (Dolby Laboratories) 与 QQ 音乐本月 27 日宣布，QQ 音乐将成为首个支持杜比旗舰音频编解码技术 AC-4 的主流音乐流媒体平台，为该平台现有的杜比全景声技术实现全新升级。","listText":"<a href=\"https://laohu8.com/S/TME\">$腾讯音乐(TME)$ </a> IT之家 3 月 30 日消息，杜比实验室 (Dolby Laboratories) 与 QQ 音乐本月 27 日宣布，QQ 音乐将成为首个支持杜比旗舰音频编解码技术 AC-4 的主流音乐流媒体平台，为该平台现有的杜比全景声技术实现全新升级。","text":"$腾讯音乐(TME)$ IT之家 3 月 30 日消息，杜比实验室 (Dolby Laboratories) 与 QQ 音乐本月 27 日宣布，QQ 音乐将成为首个支持杜比旗舰音频编解码技术 AC-4 的主流音乐流媒体平台，为该平台现有的杜比全景声技术实现全新升级。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/553431179998824","isVote":1,"tweetType":1,"viewCount":1744,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":546761046242744,"gmtCreate":1774511263500,"gmtModify":1774511265592,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 今天的成交量不多，都是小单在跑","listText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 今天的成交量不多，都是小单在跑","text":"$中慧生物-B(02627)$ 今天的成交量不多，都是小单在跑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/546761046242744","isVote":1,"tweetType":1,"viewCount":920,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":546760931095672,"gmtCreate":1774511212580,"gmtModify":1774511215394,"author":{"id":"4108169277080930","authorId":"4108169277080930","name":"音浪太强","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4108169277080930","idStr":"4108169277080930"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 智通财经APP讯，同源康医药-B(02410)发布公告，本公司将于2026年美国癌症研究协会(AACR)年会壁报环节展示TY-0609(CDK4抑制剂)、TY-2699a(CDK7抑制剂 )、 TY-2719(EGFR/FAK(PROTAC)抑制剂)、PI3Kα(PI3Kα抑制剂)、TY-1054 (YAP-TEAD抑制剂)五个在研创新药项目的研究进展和成果，此次展示的五个项目均为本公司自主研发的抗肿瘤小分子创新候选药物。本届AACR年会将于2026 年4月17日至22日在美国圣地亚哥举行，本公司参会壁报将分别于4月19日至4月 21日展示。","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 智通财经APP讯，同源康医药-B(02410)发布公告，本公司将于2026年美国癌症研究协会(AACR)年会壁报环节展示TY-0609(CDK4抑制剂)、TY-2699a(CDK7抑制剂 )、 TY-2719(EGFR/FAK(PROTAC)抑制剂)、PI3Kα(PI3Kα抑制剂)、TY-1054 (YAP-TEAD抑制剂)五个在研创新药项目的研究进展和成果，此次展示的五个项目均为本公司自主研发的抗肿瘤小分子创新候选药物。本届AACR年会将于2026 年4月17日至22日在美国圣地亚哥举行，本公司参会壁报将分别于4月19日至4月 21日展示。","text":"$同源康医药-B(02410)$ 智通财经APP讯，同源康医药-B(02410)发布公告，本公司将于2026年美国癌症研究协会(AACR)年会壁报环节展示TY-0609(CDK4抑制剂)、TY-2699a(CDK7抑制剂 )、 TY-2719(EGFR/FAK(PROTAC)抑制剂)、PI3Kα(PI3Kα抑制剂)、TY-1054 (YAP-TEAD抑制剂)五个在研创新药项目的研究进展和成果，此次展示的五个项目均为本公司自主研发的抗肿瘤小分子创新候选药物。本届AACR年会将于2026 年4月17日至22日在美国圣地亚哥举行，本公司参会壁报将分别于4月19日至4月 21日展示。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/546760931095672","isVote":1,"tweetType":1,"viewCount":1090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}